SCHEMBL4365584

SCHEMBL4365584

CC(C)(O)CC(Cl)Cl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6493268 0.78
SCHEMBL8023862 0.73
SCHEMBL7510901 0.73
SCHEMBL4057454 0.73
SCHEMBL14667647 0.72 ALDH1A1 (0.44)
SCHEMBL10647559 0.72
SCHEMBL16969672 0.72
SCHEMBL3363269 0.72
SCHEMBL10530779 0.69
SCHEMBL8831187 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114149324-B Synthesis method of 6-hydroxy-8-chlorooctanoic acid ethyl ester, 6, 8-dichloro octanoic acid ethyl ester and lipoic acid 厦门金达威维生素有限公司 2023-08-22 CN disclosed
CN-114149324-A Synthesis method of 6-hydroxy-8-chloro ethyl caprylate, 6, 8-dichloro ethyl caprylate and lipoic acid 厦门金达威维生素有限公司 2022-03-08 CN disclosed
CN-112741815-A Novel antidepressant sustained and controlled release drug delivery system 江苏集萃新型药物制剂技术研究所有限公司 2021-05-04 CN disclosed
EP-1731499-B1 PROCESS FOR PRODUCING 1,2-CIS-2-FLUOROCYCLOPROPANE-1-CARBOXYLIC ESTER COMPOUND DAIICHI SANKYO CO LTD (JP) 2014-10-01 EP disclosed
US-20090162290-A1 METHOD FOR THE SYNTHESIS OF PENTA-PENDANT ENANTIOMER-PURE CHELATORS AND PROCESS FOR THERAPEUTICALLY ACTIVE BIOCONJUGATES PREPARATION BY A COVALENT BINDING THEREOF THERAPHARM GMBH 2009-06-25 US disclosed
US-20080312430-A1 Method of Preparing or Synthesizing Polyazamacrocycle Derivatives THERAPHARM GMBH (CH) 2008-12-18 US disclosed
US-7381833-B2 Process for producing 1,2-cis-2-fluorocyclopropane-1-carboxylic ester compound DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2008-06-03 US disclosed
US-20070191626-A1 Process for producing 1,2-cis-2 fluorocyclopropane- 1carboxylic ester compound DAIICHI PHARMACEUTICAL CO., LTD (JP) 2007-08-16 US disclosed
EP-1731499-A1 PROCESS FOR PRODUCING 1,2-CIS-2-FLUOROCYCLOPROPANE-1­CARBOXYLIC ESTER COMPOUND DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2006-12-13 EP disclosed
EP-0671386-B1 Monomers derived from perhalogeneted sultones and polymers derived therefrom CENTRE NAT RECH SCIENT (FR) 1998-11-04 EP disclosed
EP-0410881-B1 Semisynthetic ganglioside analogues FIDIA SPA (IT) 1997-09-17 EP disclosed
US-5484775-A FOR INHIBITING GLUTAMATE-INDUCED NEUROTOXICITY FIDIA S.P.A. (IT) 1996-01-16 US disclosed
EP-0671386-A1 Monomers derived from perhalogeneted sultones and polymers derived therefrom CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) 1995-09-13 EP disclosed
US-4243661-A MULTHIOMYCIN ANTIBIOTIC KUMIAI CHEMICAL INDUSTRY CO., LTD. (JP) 1981-01-06 US disclosed
US-4229535-A CULTIVATING STREPTOMYCES STRAIN IN MEDIUM CONTAINING CYSTINE OR METHIONINE KUMIAI CHEMICAL INDUSTRY CO., LTD. (JP) 1980-10-21 US disclosed